137 related articles for article (PubMed ID: 2688654)
1. Modulation of deoxynucleotide metabolism by the deoxycytidylate deaminase inhibitor 3,4,5,6-tetrahydrodeoxyuridine.
Heinemann V; Plunkett W
Biochem Pharmacol; 1989 Nov; 38(22):4115-21. PubMed ID: 2688654
[TBL] [Abstract][Full Text] [Related]
2. Modulation of deoxycytidylate deaminase in intact human leukemia cells. Action of 2',2'-difluorodeoxycytidine.
Xu YZ; Plunkett W
Biochem Pharmacol; 1992 Nov; 44(9):1819-27. PubMed ID: 1449536
[TBL] [Abstract][Full Text] [Related]
3. Effect of tetrahydrouridine and deoxytetrahydrouridine on the interaction between 2'-deoxycytidine and 1-beta-D-arabinofuranosylcytosine in human leukemia cells.
Grant S; Bhalla K; McCrady C
Leuk Res; 1991; 15(4):205-13. PubMed ID: 2030601
[TBL] [Abstract][Full Text] [Related]
4. Deoxyribonucleoside triphosphate pools of herpes simplex virus infected cells: the influence of selective antiherpes agents and the role of the deaminase pathway.
Aduma PJ; Gupta SV; Stuart AL; Tourigny G
Biochem Cell Biol; 1991; 69(5-6):409-14. PubMed ID: 1654943
[TBL] [Abstract][Full Text] [Related]
5. Regulation of pyrimidine deoxyribonucleotide metabolism by substrate cycles in dCMP deaminase-deficient V79 hamster cells.
Bianchi V; Pontis E; Reichard P
Mol Cell Biol; 1987 Dec; 7(12):4218-24. PubMed ID: 3437888
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of ribonucleotide reduction in CCRF-CEM cells by 2',2'-difluorodeoxycytidine.
Heinemann V; Xu YZ; Chubb S; Sen A; Hertel LW; Grindey GB; Plunkett W
Mol Pharmacol; 1990 Oct; 38(4):567-72. PubMed ID: 2233693
[TBL] [Abstract][Full Text] [Related]
7. Concordant changes of pyrimidine metabolism in blasts of two cases of acute myeloid leukemia after repeated treatment with ara-C in vivo.
Chiba P; Tihan T; Szekeres T; Salamon J; Kraupp M; Eher R; Köller U; Knapp W
Leukemia; 1990 Nov; 4(11):761-5. PubMed ID: 2232889
[TBL] [Abstract][Full Text] [Related]
8. Antiherpes virus activity and effect on deoxyribonucleoside triphosphate pools of (E)-5-(2-bromovinyl)-2'-deoxycytidine in combination with deaminase inhibitors.
Aduma PJ; Gupta SV; De Clercq E
Antiviral Res; 1990 Mar; 13(3):111-25. PubMed ID: 2162147
[TBL] [Abstract][Full Text] [Related]
9. Changes of deoxyribonucleoside triphosphate pools induced by hydroxyurea and their relation to DNA synthesis.
Bianchi V; Pontis E; Reichard P
J Biol Chem; 1986 Dec; 261(34):16037-42. PubMed ID: 3536919
[TBL] [Abstract][Full Text] [Related]
10. Kinetic interaction of 5-AZA-2'-deoxycytidine-5'-monophosphate and its 5'-triphosphate with deoxycytidylate deaminase.
Momparler RL; Rossi M; Bouchard J; Vaccaro C; Momparler LF; Bartolucci S
Mol Pharmacol; 1984 May; 25(3):436-40. PubMed ID: 6203026
[TBL] [Abstract][Full Text] [Related]
11. Mutational specificity of DNA precursor pool imbalances in yeast arising from deoxycytidylate deaminase deficiency or treatment with thymidylate.
Kohalmi SE; Glattke M; McIntosh EM; Kunz BA
J Mol Biol; 1991 Aug; 220(4):933-46. PubMed ID: 1880805
[TBL] [Abstract][Full Text] [Related]
12. Deoxyribonucleoside triphosphate metabolism and the mammalian cell cycle. Effects of hydroxyurea on mutant and wild-type mouse S49 T-lymphoma cells.
Eriksson S; Skog S; Tribukait B; Wallström B
Exp Cell Res; 1987 Jan; 168(1):79-88. PubMed ID: 3096753
[TBL] [Abstract][Full Text] [Related]
13. Regulatory effects of deoxyribonucleosides on the activity of 5-methoxymethyl-2'-deoxycytidine: modulation of antiherpes activity by deoxyguanosine and tetrahydrodeoxyuridine.
Aduma PJ; Gupta SV; Stuart AL; Tourigny G
Antiviral Res; 1991 May; 15(4):301-13. PubMed ID: 1659312
[TBL] [Abstract][Full Text] [Related]
14. Differential modulation of 1-beta-D-arabinofuranosylcytosine metabolism by hydroxyurea in human leukemic cell lines.
Kubota M; Takimoto T; Tanizawa A; Akiyama Y; Mikawa H
Biochem Pharmacol; 1988 May; 37(9):1745-9. PubMed ID: 2454114
[TBL] [Abstract][Full Text] [Related]
15. 2',3'-Dideoxycytidine toxicity in cultured human CEM T lymphoblasts: effects of combination with 3'-azido-3'-deoxythymidine and thymidine.
Törnevik Y; Eriksson S
Mol Pharmacol; 1990 Aug; 38(2):237-43. PubMed ID: 2166904
[TBL] [Abstract][Full Text] [Related]
16. Cellular elimination of 2',2'-difluorodeoxycytidine 5'-triphosphate: a mechanism of self-potentiation.
Heinemann V; Xu YZ; Chubb S; Sen A; Hertel LW; Grindey GB; Plunkett W
Cancer Res; 1992 Feb; 52(3):533-9. PubMed ID: 1732039
[TBL] [Abstract][Full Text] [Related]
17. Compartmentation of dCTP pools disappears after hydroxyurea or araC treatment in lymphocytes.
Spasokukotskaja T; Sasvári-Székely M; Taljanidisz J; Staub M
FEBS Lett; 1992 Feb; 297(1-2):151-4. PubMed ID: 1551421
[TBL] [Abstract][Full Text] [Related]
18. Role of uridine triphosphate in the phosphorylation of 1-beta-D-arabinofuranosylcytosine by Ehrlich ascites tumor cells.
White JC; Hines LH
Cancer Res; 1987 Apr; 47(7):1820-4. PubMed ID: 3028615
[TBL] [Abstract][Full Text] [Related]
19. Human immunodeficiency virus type 1 induces 1-beta-D-arabinofuranosylcytosine resistance in human H9 cell line.
Yusa K; Oh-hara T; Tsukahara S; Tsuruo T
J Biol Chem; 1992 Aug; 267(24):16848-50. PubMed ID: 1512227
[TBL] [Abstract][Full Text] [Related]
20. The effect of ara-C-induced inhibition of DNA synthesis on its cellular pharmacology.
Wang LM; White JC; Capizzi RL
Cancer Chemother Pharmacol; 1990; 25(6):418-24. PubMed ID: 2311169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]